Endolaksoff (Powder) Instructions for Use

Marketing Authorization Holder

Pharmacor Production, LLC (Russia)

ATC Code

A06AD15 (Macrogol)

Active Substance

Macrogol (Rec.INN registered by WHO)

Dosage Form

Endolaksoff®

Powder for oral solution 64 g: 4 pcs. sachet

Dosage Form, Packaging, and Composition

Powder for preparation of oral solution white or almost white in color. The presence of small agglomerates is allowed.

Excipients: anhydrous sodium sulfate, sodium bicarbonate, sodium chloride, potassium chloride, sodium saccharin.

73.69 g – thermowelded sachets made of combined material (4) (4 individual sachets or 2 double sachets) – cardboard packs.

Clinical-Pharmacological Group

Laxative drug with osmotic properties

Pharmacotherapeutic Group

Osmotic laxative

Pharmacological Action

Osmotic laxative. Polyethylene glycol with a molecular weight of 4000. The laxative effect develops due to the ability to increase the volume of intestinal contents, due to the fluid contained in it, which leads to increased peristalsis.

Pharmacokinetics

Not absorbed from the gastrointestinal tract and not metabolized.

Indications

Symptomatic treatment of constipation.

Preparation for diagnostic examinations (endoscopic, radiological) and surgical interventions on the colon.

ICD codes

Dosage Regimen

Determine the dose, route, and schedule individually based on indication and patient age.

For symptomatic treatment of constipation in adults and adolescents over 12 years, administer the contents of one sachet dissolved in 250 ml of water orally once daily.

Adjust the daily dose based on clinical response; the usual effective dose is one sachet per day.

For bowel preparation before diagnostic procedures or surgery, use a split-dose regimen.

On the day before the procedure, administer the contents of two sachets dissolved in 500 ml of water in the evening.

On the day of the procedure, administer the contents of two sachets dissolved in 500 ml of water in the morning, finishing intake at least 2 hours before the examination.

Administer each dose over approximately 30-60 minutes.

For patients with a nasogastric tube, administer the prepared solution via the tube.

In pediatric patients, use only age-appropriate formulations and strictly adhere to recommended pediatric dosing.

Maintain an interval of at least 2 hours between administration of this drug and other orally administered medications.

Discontinue use if severe abdominal pain, distension, or vomiting occurs.

Adverse Reactions

From the digestive system frequently – abdominal bloating, abdominal pain, nausea, diarrhea; rarely – vomiting, urgent defecation urge and fecal incontinence, irritation of the perianal area.

From the metabolism frequently – electrolyte imbalance (hyponatremia, hypokalemia) and/or dehydration, especially in elderly patients.

Allergic reactions frequency unknown – skin itching, urticaria, skin rash, facial edema, angioedema, anaphylactic shock, erythema, fulminant and acute pulmonary edema (after administration of a balanced macrogol solution with electrolytes via a nasogastric tube).

Contraindications

Hypersensitivity to the drug, dehydration, severe chronic heart failure; presence of a malignant tumor or other disease of the colon accompanied by extensive damage to the intestinal mucosa; gastric ulcer, erosive-ulcerative lesions of the colon mucosa (including ulcerative rectocolitis, Crohn’s disease); severe inflammatory bowel diseases or toxic megacolon combined with symptomatic stenosis, perforation or risk of hollow organ perforation, intestinal obstruction (including spastic, obturation); impaired gastric emptying (including gastroparesis), abdominal pain of unclear etiology; children’s age – depending on the dosage form.

With caution in renal impairment, heart failure; in patients with impaired swallowing reflex, reflux esophagitis; in patients on concomitant diuretic therapy; in patients prone to developing water-electrolyte imbalance, including hyponatremia and hypokalemia; in patients with neurological disorders, in bedridden patients and/or patients with motor function impairments, in patients prone to aspiration, and/or in a semi-conscious state; in elderly patients.

Use in Pregnancy and Lactation

During pregnancy and breastfeeding, it should be used only after consultation with a doctor, in cases where the intended benefit to the mother outweighs the potential risk to the fetus or infant.

Use in Renal Impairment

Should be used with caution in patients with renal impairment.

Pediatric Use

Can be used in children according to indications, in age-appropriate recommended doses and dosage forms. It is necessary to strictly follow the instructions in the macrogol drug leaflets regarding contraindications for the use of specific macrogol dosage forms in children of different ages.

Geriatric Use

Should be used with caution in elderly patients.

Special Precautions

Elderly patients with various concomitant diseases are recommended to use Macrogol under the supervision of medical personnel.

Caution should be exercised when using the drug D-Forject in patients with inflammation of the intestinal mucosa, including the rectum.

Macrogol should be used with caution and only under the supervision of medical personnel in patients prone to aspiration, in bedridden patients, in patients with neurological disorders and/or in patients with impaired motor functions due to the risk of aspiration pneumonia. In such patients, Macrogol should be administered in a sitting position and via a nasogastric tube.

Patients in a semi-conscious state should be under close observation during the administration of macrogol. If symptoms of abdominal pain or bloating appear, the rate of macrogol administration should be reduced or administration should be suspended until these symptoms disappear.

Drug Interactions

Diarrhea caused by macrogol intake can lead to impaired absorption of other concurrently taken drugs. In this case, the effectiveness of drugs with a narrow therapeutic index or a short half-life may be reduced. The patient should inform the doctor who prescribed Macrogol about all concurrently taken medications.

The interval between taking macrogol and other drugs should be at least 2 hours.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.